PHARMACEUTICAL BIOLOGY, published by Taylor & Francis Ltd, is a prominent open-access journal that has been a cornerstone of research in the life sciences since its convergence in 1961. With a strong focus on Complementary and Alternative Medicine, Pharmaceutical Science, and Drug Discovery, this journal is dedicated to disseminating groundbreaking research that intersects pharmaceuticals and biology. Acknowledged for its rigorous peer-review process, it holds a prestigious Q1 ranking in Pharmaceutical Science and exemplifies the commitment to quality and impact in the field, boasting an impressive Scopus rank of #14/105 in the complementary and alternative medicine category. Researchers keen on advancing their knowledge in these fields will find PHARMACEUTICAL BIOLOGY an invaluable resource, offering accessibility since its shift to open access in 2017. This journal presents a platform for innovative studies that contribute to the evolving understanding of pharmaceutical applications and biological interactions, serving as an essential hub for researchers, professionals, and students alike.

PLANTA MEDICA is a premier journal dedicated to advancing the field of medicinal plant research, published by Georg Thieme Verlag KG in Germany. With an ISSN of 0032-0943 and an E-ISSN of 1439-0221, this journal has been a cornerstone of scholarly communication since its inception in 1961. Recognized for its rigorous peer-review process, PLANTA MEDICA holds a notable reputation in the academic landscape, featuring a 2023 Q2 ranking in categories such as Analytical Chemistry and Pharmaceutical Science, along with respectable Q3 rankings in Drug Discovery and Molecular Medicine. The journal focuses on the synthesis, pharmacological, and biochemical assessment of phytochemicals, making it an essential resource for researchers, professionals, and students alike who are engaged in the exploration of complementary and alternative medicine. Although it does not offer open access options, its content is instrumental in identifying new therapeutic agents derived from plants, thereby underscoring its importance in drug discovery and holistic health research.

Chinese Medicine is a distinguished open-access journal published by BMC, focusing on the advancement of knowledge and practice in the domain of complementary and alternative medicine. With the ISSN 1749-8546, this journal has established itself as an important resource for researchers, professionals, and students interested in the integration of traditional Chinese medicine with modern scientific practices. Since its inception in 2006, it has garnered a notable reputation, achieving a Q1 ranking in Complementary and Alternative Medicine and Q2 in Pharmacology for 2023, reflecting its high impact and relevance within the academic community. The journal's commitment to disseminating quality research is evident in its Scopus rankings, placing it in the top decile for medicine and pharmacology disciplines. Open access since its launch, Chinese Medicine promotes widespread accessibility and encourages collaborative scholarly efforts in investigating the efficacy and applications of traditional practices in contemporary healthcare. By fostering a platform for rigorous discourse and innovative research, this journal serves as an essential conduit for advancing the understanding of Chinese medicine's role in global health.

Frontiers in Pharmacology, published by FRONTIERS MEDIA SA, stands as a leading open-access journal dedicated to advancing the field of pharmacology since its inception in 2010. With its ISSN 1663-9812, the journal is based in Switzerland and maintains a vital role in disseminating innovative research findings that span various disciplines within pharmacology, including pharmacokinetics, toxicology, and pharmacogenetics. In 2023, Frontiers in Pharmacology has achieved an impressive standing within the scientific community, being ranked in the Q1 category for both general and medical pharmacology, highlighting its critical contribution to the field with a Scopus ranking of #41 out of 272 in medical pharmacology and #76 out of 313 in pharmacology, toxicology, and pharmaceutics, placing it in the 75th and 85th percentiles, respectively. Researchers and practitioners benefit from its open-access model, which ensures widespread accessibility to groundbreaking research, fostering collaboration and innovation across the pharmaceutical sciences. With its commitment to excellence, Frontiers in Pharmacology serves as an essential resource for those looking to explore and contribute to the latest advancements in pharmacological research.

Traditional & Kampo Medicine is a distinguished journal published by Wiley, focusing on the rich traditions and scientific advancements in complementary and alternative medicine, particularly within the realms of Traditional Chinese medicine and Kampo. With an E-ISSN of 2053-4515, this journal serves as a pivotal platform for researchers, professionals, and students interested in exploring the integration and evidence-based application of traditional healing practices in contemporary medical contexts. Since its inception in 2014 and projected until 2024, it has carved out a notable place in academic contributions, being ranked in the 3rd quartile for Complementary and Alternative Medicine and the 4th quartile for Pharmacology (Medical) as of 2023. While the access options are not explicitly stated, the journal fosters scholarly debate and disseminates innovative findings that underscore the importance of traditional healing methodologies within modern healthcare paradigms. By bridging ancient wisdom and scientific inquiry, Traditional & Kampo Medicine plays a crucial role in advancing the understanding and application of holistic health approaches.

ACUPUNCTURE & ELECTRO-THERAPEUTICS RESEARCH, published by COGNIZANT COMMUNICATION CORP, is a pivotal journal that delves into the intricate relationship between acupuncture, electro-therapeutics, and their applications in the fields of anesthesiology, pain medicine, and complementary therapies. With an ISSN of 0360-1293 and an E-ISSN of 2167-9010, this esteemed journal has been serving the academic community since 1976 and will continue to publish groundbreaking research until 2024. Despite its current positioning within the Q4 quartiles for both anesthesiology and complementary medicine, ACUPUNCTURE & ELECTRO-THERAPEUTICS RESEARCH remains a valuable platform for disseminating innovative studies that push the boundaries of traditional pain management and neuroscience. Researchers, students, and professionals interested in exploring contemporary therapeutic modalities will find this journal an indispensable resource for understanding the efficacy and applications of acupuncture and electro-therapeutics. With a focus on advancing knowledge in these domains, the journal aims to foster a deeper understanding of integrative approaches to health and wellness.

The Chinese Journal of Natural Medicines, published by the esteemed CHINESE JOURNAL NATURAL MEDICINES, plays a pivotal role in the exploration and advancement of complementary and alternative medicine. With an ISSN of 2095-6975 and an E-ISSN of 1875-5364, this journal is recognized for its commitment to high-quality research and innovative findings in the realms of drug discovery and miscellaneous medical fields. Operating from China, it has earned a prestigious reputation in the academic community, achieving Q1 status in Complementary and Alternative Medicine and Q2 rankings in both Drug Discovery and Miscellaneous Medicine as of 2023, solidifying its influence within the scientific discourse. Researchers and professionals will find valuable insights here as the journal explores the intersection of traditional natural medicines with modern pharmacological science, making it an essential resource for anyone dedicated to the field. With a convergence period from 2004 to 2024, the journal continues to champion open dialogue and disseminate significant findings critical for the development of effective natural therapies.

Jundishapur Journal of Natural Pharmaceutical Products, published by BRIEFLAND in the Netherlands, serves as a pivotal platform for researchers and professionals in the realm of pharmacology and toxicology. With its ISSN 1735-7780 and E-ISSN 2228-7876, the journal has established itself since its inception in 2011, showcasing a commitment to advancing knowledge in natural pharmaceutical products through innovative research. In 2023, it earned a commendable ranking in the Q3 category for Pharmacology, Toxicology, and Pharmaceutics, reflecting its contribution to the field as evidenced by its position in the Scopus rankings. The journal aims to publish high-quality research articles, reviews, and case studies that explore the potential benefits and toxicological aspects of natural products. Although it currently does not offer open access, its rigorous peer-review process ensures that only impactful studies are disseminated, ultimately facilitating a deeper understanding of natural pharmaceutical innovations. For those engaged in this exciting and evolving field, Jundishapur Journal of Natural Pharmaceutical Products is an essential resource that not only expands scholarly discourse but also promotes safe practices in natural product utilization.

Journal of the Chinese Medical Association, published by LIPPINCOTT WILLIAMS & WILKINS, is a prominent peer-reviewed journal in the field of general medicine, specifically focused on advancements and research within the Chinese medical community. Established in 2003 and with a scope that spans diverse medical disciplines, this journal has positioned itself as a key resource for medical professionals, researchers, and academics interested in both clinical practices and health policy in Taiwan and the broader context of Asian medicine. With an impressive Scopus ranking of 69 out of 636 in the general medicine category and a notable percentile rank of 89th, the journal is recognized for its contributions to medical science. Although it does not currently provide open access options, it continues to maintain a robust presence through its high-quality publications and rigorous peer-review process aimed at fostering innovation and sharing critical insights across the medical field. Researchers and students alike will find this journal an invaluable platform for disseminating their findings and engaging with current medical discourse.

Advances in Traditional Medicine, published by SPRINGER, stands at the forefront of the Complementary and Alternative Medicine field, dedicated to exploring the intricate landscapes of traditional medical practices worldwide. With an impressive 2023 Q2 ranking and a Scopus rank of #30/105, this journal is committed to advancing scholarly discourse and innovation in the study and practice of traditional medicine, making it an essential resource for researchers, practitioners, and students alike. As an Open Access journal, it ensures wide accessibility to cutting-edge research and developments from 2020 to 2024, fostering collaboration and knowledge exchange in the global medical community. Based in Singapore, with operations linked to VAN GODEWIJCKSTRAAT 30, 3311 GZ Dordrecht, Netherlands, this journal not only enhances its reach but also enriches the academic landscape with its significant contributions to understanding the role of traditional medicine in contemporary healthcare.